Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo compound, E-6011, shows a promising treatment aimed at the PD-1 receptor. Initial medical data from these initiatives, KANAb 001 and E-6011, suggest significant response in multiple malignancy forms. Notably, data point to a poss